- All sections
- C - Chemistrymetallurgy
- C07F - Acyclic, carbocyclic, or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium
- C07F 9/30 - Phosphinic acids [R2=P(:O)OH]Thiophosphinic acids
Patent holdings for IPC class C07F 9/30
Total number of patents in this class: 412
10-year publication summary
|
22
|
19
|
18
|
14
|
18
|
12
|
25
|
37
|
34
|
28
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| BASF SE | 21101 |
30 |
| Clariant Finance (BVI) Limited | 381 |
28 |
| Lier Chemical Co., Ltd. | 42 |
28 |
| UPL Limited | 609 |
19 |
| Merck Patent GmbH | 5733 |
11 |
| Hangzhou DAC Biotech Co., Ltd | 106 |
9 |
| Kallyope, Inc. | 61 |
9 |
| Guangan Lier Chemical Co., Ltd. | 10 |
9 |
| Zhejiang University | 3281 |
6 |
| Zhejiang Wynca Chemical Industry Group Co., Ltd. | 18 |
6 |
| YongNong BioSciences Co., Ltd. | 16 |
6 |
| Ningxia Yongnong Biosciences Co., Ltd. | 12 |
6 |
| AstraZeneca AB | 2832 |
5 |
| Allergan, Inc. | 2309 |
5 |
| CJ Cheiljedang Corporation | 3511 |
5 |
| Metabasis Therapeutics, Inc. | 40 |
5 |
| Ningbo Institute of Materials Technology & Engineering, Chinese Academy of Sciences | 169 |
5 |
| Strategic Enzyme Applications, Inc. | 8 |
5 |
| Arch Biopartners, Inc. | 10 |
5 |
| Centre National de La Recherche Scientifique | 10708 |
4 |
| Other owners | 206 |